This observation is of particular interest, as pancreatic cancer cells often develop resistance to intrinsic apoptotic signaling due to multiple molecular alterations affecting the mitochondrial pathway, such as p53 mutations and the dysregulation of Bcl-2 family proteins [33,34,35]. The gene discussed is TP53; the disease is familial pancreatic carcinoma.